Opko Health (OPK) Amortization of Deferred Charges (2013 - 2026)
Opko Health (OPK) reported Amortization of Deferred Charges of $137000.0 for Q1 2026, down 97.05% on a YoY basis from $4.6 million in Q1 2025, and down 99.78% quarter-over-quarter from $61.2 million in Q4 2025.
Opko Health (OPK) Amortization of Deferred Charges (2013 - 2026) Analysis & Trends
Opko Health has reported Amortization of Deferred Charges for 14 years, with the latest figure at $137000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges fell 97.05% year-over-year to $137000.0; the trailing twelve-month figure through Mar 2026 stood at $61.7 million (up 243.83% YoY), and the FY2025 full-year result was $66.3 million, up 277.6% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $137000.0, down from $61.2 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $61.2 million in Q4 2025, with the low at -$56.5 million in Q3 2025.
- Historically, Amortization of Deferred Charges has averaged $5.2 million across 5 years, with a median of $693000.0 in 2022.
- Annual changes were most pronounced in 2024 — Amortization of Deferred Charges soared 2594.7% — and 2025, when it slumped 4351.51%.
- Opko Health's Amortization of Deferred Charges stood at $693000.0 in 2022, then plunged by 220.49% to -$835000.0 in 2023, then jumped by 259.04% to $1.3 million in 2024, then jumped by 4505.42% to $61.2 million in 2025, then slumped by 99.78% to $137000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $137000.0 (Q1 2026), $61.2 million (Q4 2025), and -$56.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Opko Health | 1.09 Bn | 747.11 Mn | 45.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 137,000.00 |
| Mar 31, 2026 | 137,000.00 |
| Dec 31, 2025 | 61.16 Mn |
| Dec 31, 2025 | 61.16 Mn |
| Sep 30, 2025 | -56.46 Mn |
| Sep 30, 2025 | -56.46 Mn |
| Jun 30, 2025 | 56.91 Mn |
| Jun 30, 2025 | 56.91 Mn |
| Mar 31, 2025 | 4.65 Mn |
| Mar 31, 2025 | 4.65 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 8.14 Mn |
| Jun 30, 2024 | 8.14 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Dec 31, 2023 | -835,000.00 |
| Dec 31, 2023 | -835,000.00 |
| Sep 30, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.46 Mn |